In conclusion, our study demonstrated that CD38 deficiency significantly alleviated Ang II-induced hypertension and vascular remodeling by inhibiting the SA-sEV-mediated senescence of VSMCs. The gene discussed is CD38; the disease is hypertensive disorder.